Background
Obesity is one of the most prevalent chronic diseases and a growing public health burden, resulting from complex interactions between genetic, environmental, and neuroendocrine mechanisms that regulate energy homeostasis. Because lifestyle modifications alone frequently fail to maintain long-term weight redu...
Dagmara Laufer, Olga Klimczak, Filip Chodań et al.· Archiv Euromedica· 0 citations
Background
Hidradenitis suppurativa (HS) is a chronic, profoundly debilitating inflammatory skin disease characterized by deep-seated nodules, abscesses, and discharging sinus tracts. Its complex pathogenesis is driven by a dynamic interplay between a disrupted skin microbiome and an aberrant host immune response, resu...
Krystian Domeracki, Olga Klimczak, Filip Chodań et al.· Archiv Euromedica· 0 citations
Teprotumumab currently has the strongest evidence for improving disease activity, proptosis, and diplopia, whereas the clinical roles of rituximab, tocilizumab, and emerging biologic agents remain less clearly defined.
Filip Chodań, Krystian Domeracki, Dagmara Laufer et al.· Archiv Euromedica· 0 citations
Background
Rumination syndrome is an underrecognized disorder of gut–brain interaction characterized by recurrent, effortless postprandial regurgitation resulting from maladaptive behavioral and gastrointestinal motor mechanisms. Although growing evidence has improved understanding of its epidemiology, pathophysiology,...
Filip Chodań, Karol Kajda, Estera Sośniecka et al.· Archiv Euromedica· 0 citations
Background
Chemotherapy induced nausea and vomiting remain among the most common adverse effects of anticancer treatment, affecting up to 80% of patients. Despite effective antiemetic prophylaxis, complete symptom control is not consistently achieved, particularly for nausea and delayed CINV. These symptoms impair qual...
Filip Chodań, Dagmara Laufer, Olga Klimczak et al.· Archiv Euromedica· 0 citations
This review of established and emerging targeted therapies for SLE, including CAR T cell therapy, with emphasis on mechanisms, efficacy, safety, regulatory status, and clinical roles, finds that approaches differ in regulatory status and clinical readiness.
Filip Chodań, Estera Sośniecka, Olga Klimczak et al.· Archiv Euromedica· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.